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Abstract
The fatty acid-binding proteins (FABPs) are a family of nine structurally related
proteins, which bind to long-chain fatty acids with high affinity. Fatty acid binding
proteins were first discovered in 1972, while conducting studies on the factors that
regulate the uptake of intestinal fatty acids in rats. These proteins are most
abundantly found in the tissues engaged in active lipid metabolism. Adipocyte fatty
acid binding protein or aP2 is a member of this family, which is found in adipocytes
and macrophages and integrates metabolic and inflammatory responses (Furuhashi
et al., 2007).
Studies on aP2 knockout mice have shown that aP2 null mice were more
insulin sensitive compared to their wild type counterparts when kept on a high fat
diet. This lipid chaperone plays an important role in metabolic syndromes, including
type 2 diabetes and atherosclerosis. Targeting aP2 with small-molecule inhibitors can
lead to a new class of therapeutic agents that may provide a model of study to
prevent metabolic diseases such as type 2 diabetes.
This study focuses on the purification of aP2 by ion exchange chromatography
in preparation for co-crystallization with ibuprofen. Previous attempts to do this have
failed due to the tight binding of fatty acid at the binding site of the protein. To
overcome this issue, delipidation was attempted by means of chromatography using
the Lipidex 1000 sorbent. The purified protein was crystallized using the hanging
drop method with seeding in the presence of ibuprofen. This study describes the
crystal structure of human aP2 with bound ibuprofen at 1.4 Å resolution. Crystalline
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aP2 was orthorhombic with cell dimensions of a = 32.20 Å, b = 53.64 Å, c = 74.44 Å
and the space group was P212121.
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Chapter 1: Introduction
Fatty Acid-binding Proteins
The fatty acid-binding proteins (FABPs) are a family of nine structurally related
proteins, which bind to long-chain fatty acids with high affinity. The intracellular lipid
binding proteins provide cytosolic shuttles for the solubilization, transfer and storage
of fatty acids in eukaryotic cells (Marr et al., 2006). They solublize hydrophobic
ligands and transport them to appropriate metabolic systems for proper utilization
(Baxa et al., 1989).
The members of the FABP family display a unique pattern of tissue expression
(Ockner, 1990). As mentioned earlier, they are expressed in tissues involved in the
metabolism of lipids. The members of the family include liver, intestinal, heart,
adipocyte, epidermal, ileal, brain, myelin and testis fatty-acid binding proteins. As
shown in table 1, the FABP’s are not necessarily found in only one tissue. Different
cell or tissue types have also been found to express many FABP isoforms (Furuhashi
et al., 2007).
FABP’s contribute to about 1-5% of the soluble intracellular proteins in
acipocytes, cardiac myocytes and hepatocytes as they are required for the synthesis,
storage and breakdown of lipids.
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Table 1
The family of fatty acid binding proteins and the expression of FABP gene.
Common name

Alternative name

Tissue type

Liver FABP

L- FABP

Intestinal FABP

I- FABP

Liver, intestine, pancreas,
kidney, lung, stomach
Intestine, liver

Heart FABP

H- FABP

Adipocyte FABP

A- FABP, aP2, ALBP,p15

Epidermal FABP

E- FABP, mal1

Ileal FABP

Il- FABP

Heart, skeletal muscle,
brain, adrenal gland
Adipocyte, macrophage,
dendritic cell
Skin, tongue, adipose
tissue, mammary gland
Ileum, ovary

Brain FABP

B- FABP

Brain

Myelin FABP

M- FABP

Peripheral nervous system

Testis FABP

T- FABP

Testis

An increase in fatty acid level results in increased levels of the FABP’s. High
levels of FABP’s have been observed in skeletal muscle cells during diabetes and
similar expression patterns have also been observed in adipocytes and hepatocytes.
Though the regulation of expression of FABP’s in different tissue types is not well
understood, the pattern suggests that there is a built in mechanism, which responds
to changing fatty acid levels in the cells.
Adipose Tissue and Adipocytes
Adipose tissue stores energy as triglycerides and is also important in signaling
energy balance status. Almost half of the adipose tissue cells consist of adipocytes.
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There are two types of adipose tissue. White adipose tissue (WAT) stores energy as
fat and Brown adipose tissue (BAT) converts energy into heat. Adipocyte fatty acidbinding protein (A-FABP) is nearly 1-3% of the total soluble adipocyte protein
(Reese-Wagoner, 1999).
AP2 (FABP4) and mal1 (FABP5) are two isoforms of FABP, which are
expressed in adipocytes and macrophages. Adipocyte fatty acid-binding protein is a
dominant isoform in adipocytes. However, the expression of aP2 and mal1 is similar
in activated macrophages. The regulation of aP2 and mal1 is through metabolic and
inflammatory mediators. This information is an important link between obesity and
inflammation because the inflammation that arises from adipocytes suppresses the
insulin signaling pathway, thereby making way for type 2 diabetes (Wellen &
Hotamisligil, 2005).
Trafficking of Fatty Acids in the Adipocyte
Fatty acids, which are destined for adipose cells circulate in plasma as
triglycerides attached to lipoprotein particles. Lipoprotein lipase hydrolyzes the
triglyceride-lipoprotein complex liberating fatty acids, which are bound by serum
albumin.
The mechanism by which albumin-bound fatty acids pass through the
endothelial cell layer is not known. It has been postulated that it may interact with the
adipocyte plasma membrane to stimulate fatty acid uptake. The effects of serum
albumin on the uptake of long-chain fatty acids was studied by Trigatti and Gerber in
3T3-L1 adipocytes, a murine cell line which differentiated from preadipocytes to
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adipocytes. The role of serum albumin in the uptake of long- chain fatty acids has
been assumed to be the solubilization of fatty acid in the aqueous environment.
Serum albumin provides a reservoir of bound fatty acid to replenish uncomplexed
fatty acid, degraded by cellular uptake.
he experiment was conducted using 3T3-L1 adipocytes to test the cellular
uptake of oleate in a saturable manner at all ratios of oleate to bovine serum albumin
(BSA) was tested. It was found that oleate uptake was linearly proportional to the
ratio of oleate to the BSA present. It was also found that an increase in the
concentration of BSA had a stimulatory effect on oleate uptake. To test if the
stimulatory effect was due to a direct interaction between BSA and the cell surface,
BSA was labeled with a photo-reactive long-chain fatty acid. The results showed that
3T3-L1 adipocytes utilized BSA-complexed fatty acids as substrates for uptake,
which also involved interaction between BSA and the cell surface (Trigatti & Gerber,
1995).
Trigatti and Gerber also identified that caveolin; a 3T3-L1 adipocyte plasma
membrane protein has the capability of binding to photo-reactive fatty acid analogue
as a possible transporter. Caveolin is a component of plasmalemmal vesicles, which
form pits in the plasma membrane of adipocytes and other cell types.
The trafficking patterns for fatty acid have not been clearly established. It has
been thought by some that the plasma membrane transporters carry fatty acids to
acyl CoA synthetases, which are present on several internal membranes. Acyl CoAs
are then utilized for the synthesis of membranes and triacylglycerol. The trafficking of
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lipid binding protein affects only those acyl CoA synthetases which utilize long chain
fatty acids (Bernlohr, Coea, & LiCatab, 1999).
Structure of FABP’s
Fatty acid-binding proteins are a family of small monomeric cytoplasmic
proteins, with a molecular mass of 14-15 kDa. So far, nine members have been
found. Their expression pattern depends on the type of tissue in which they are
found. They are expressed most abundantly in tissues, which are involved in the
metabolism of lipids (Furuhashi et al., 2007).
Expression of FABP’s is determined by the metabolic demand of the cells.
FABP’s are lipid chaperones; they help in the transport of lipids to various
compartments of the cells. The endoplasmic reticulum uses them for signaling,
trafficking and synthesis of membranes. Mitochondria use them for oxidation, and the
nucleus uses them for the regulation of transcription, mediated via lipids (Furuhashi
et al., 2007).
The gene structure of FABP’s is conserved. It consists of four exons and three
introns. The members of this family share 15% to 70% sequence identity and their
tertiary structure is superimposable and almost identical. A β-barrel is formed by 10
β-strands, which run anti-parallel to each other around a ligand-binding cavity. The
opening is enveloped on one side by the N-terminal helix-loop-helix cap domain
(Erbay, Cao, & Hotamisligil, 2007).
The ligand is believed to enter the cavity through the region between the barrel
and the lid. Inside the cavity, the carboxylate group interacts with a tyrosine and two
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arginine residues by electrostatic forces of attraction. The helical N-terminus is
thought by some to be crucial for electrostatic interaction between FABP’s and
membranes (Chmurzynska, 2006).
The fatty acid binding affinity directly relates with the hydrophobicity of the fatty
acid. The binding of the ligand also inflicts a subtle change in the three dimensional
structure of the protein, which may promote specific protein-protein or proteinmembrane interactions thereby determining the function of each FABP (Storch,
2009).
Structure of Adipocyte Fatty Acid-binding Protein
The Adipocyte fatty acid-binding protein (A-FABP, ALBP, 422 protein, aP2 and
p15) is a member of the intracellular lipid-binding protein family and it has a
molecular mass of 14.5 kDa (Simpson, LiCata, Ribarik, & Bernlohr, 1999). The
crystal structure of human aP2 is a β-barrel, which is formed by 10 β-strands, which
run anti-parallel to each other around a ligand-binding cavity. The opening is
enveloped on one side by the N-terminal helix-loop-helix cap domain (Erbay et al.,
2007).
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Figure 1. The crystal structure of aP2 with the internal cavity for ligand binding.
The inside of the barrel is a large water-filled cavity lined with polar and
hydrophobic amino acids. The cavity is capable of receiving medium and long- chain
fatty acids as well as other amphiphilic molecules. The ligand enters the cavity
through the region between the barrel and the lid. The area near the lid along with
the reverse turn loops is called ‘portal’ and is thought to be a region for the entry and
exit for the ligand.
Inside the cavity, the carboxylate group of the fatty acid forms hydrogen bonds
with the hydroxyl group of Tyr128 as well as the nitrogen atom of Arg126. The other
oxygen atom of the fatty acid interacts with aP2 via water-mediated hydrogen bonds.
The hydrophobic chain of the fatty acid binds in the pocket through hydrophobic
interaction with various residues such as Phe16, Met20 and Phe57 (Marr et al.,
2006).
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aP2 and Type 2 Diabetes
Obesity leads to dysfunction of adipose tissue involving metabolic, oxidative
and endoplasmic reticulum stress. These factors activate stress-responsive signaling
pathways, which result in metabolic, inflammatory and endocrine alterations, thereby
contributing to the co-morbidities linked with obesity (Rudich, Kanety, & Bashan,
2007).
Obesity and the pathologies associated with it have become a global threat to
human health. Previous studies have established that the body reacts to infection
and obesity in a similar fashion. These conditions set off low-level chronic and local
inflammation, which arises from the adipose tissue (Tuncman et al., 2006). The
inflammatory responses are characterized by abnormal production of cytokines and
acute phase reactants, which further turns on the inflammatory signaling pathways
(Wellen & Hotamisligil, 2003).
The inflammatory responses normally work on metabolic support and energy
redistribution, thus favoring catabolic pathways over the anabolic state, thereby
curbing the insulin signaling pathway (Wellen et al., 2005). This inflammatory
response paves the way for the progression of type 2 diabetes and other obesity
related pathologies. Fatty acid binding proteins (FABP’s) have been found to link
metabolic and inflammatory responses in experimental models (Tuncman et al.,
2006).
A study conducted by Makowski and Hotamisligil substantiates the claims
mentioned above. Several models of FABP null mice have been created to study the
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effects of altered fatty acid-binding capacity. Though all the models show alteration in
lipid metabolism, only aP2-and mal1-deficient mice have been signalized for the
development of metabolic syndrome. The phenotype of the aP2 -/- mice did not show
any defects in adipose tissue, reproduction, or growth.
The mice were kept on a diet high in fat to initiate stress on lipid pathways.
When compared with aP2+/+ controls, the aP2 null mice were protected from insulin
resistance. Though the aP2 null mice had high levels of free fatty acid in the plasma,
they had decreased cholesterol and triglyceride levels.
The aP2 deficient mice were then crossed with leptin deficient (ob/ob) mice to
verify if the insulin sensitivity was due to the action of leptin. The results indicated that
protection against insulin resistance was not due to leptin signaling. The two obesity
models indicated that aP2 deficiency altered the metabolism of fatty acids and
protected the animals from developing systemic insulin resistance (Makowski &
Hotamisligil, 2004; Jequire, 2002).
A study was conducted on a genetic variation at the aP2 locus, which caused
aP2 haploinsufficiency and was found to reduce the risk of type 2 diabetes. The
alteration of the binding of the CAAT box/ enhancer-binding protein was found to
reduce the transcription activity of the aP2 promoter, which resulted in a significant
decrease in aP2 expression. The aP2 gene, mapped on 8q21 chromosome encodes
a 131-aa protein. To study the genetic variation at the aP2 locus, 96 men and women
were selected and the DNA sequence for the promoter and coding regions was
determined (Tuncman et al., 2006).
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A single nucleotide polymorphism (SNP) where Thymine (T) was replaced by
Cytosine (C) at position -87 in the 5’ promoter region was identified. The location of
T-87C is at the binding site of the CAAT box/ enhancer-binding protein (C/EBP)
(Tuncman et al., 2006). Due to the SNP, the recognition site gets altered. For the
experiment, the binding of C/EBPα, which a transcriptional factor for the
differentiation of precursor cells into fat cells, was examined. The ability of the T-87C
variant to interact with C/EBPα protein was tested and compared with the wild type. It
was found that binding to the wild type CAAT box was much higher compared to the
T-87C variant (Tuncman et al., 2006).
This finding was further pursued and studied by Wellen and Hotasmisligil to
find the association between metabolism and inflammation in reference to diabetes
and inflammation. They argued that TNF-α is a link between inflammation and
diabetes. Obese humans and mice, both show elevated levels of TNF-α in the
adipose tissue. Mice lacking TNF-α show improved insulin sensitivity compared to
the wild type. The study indicated that many mediators of the inflammatory response
have similar pattern of expression as that of TNF-α during obesity.
Gokhan et al., have reported that mice with a null mutation in the aP2 gene,
when placed on a high fat diet (40% of total calories in the form of fat), were
significantly protected from hyperinsulinemia and insulin resistance compared to wild
type. Also the obese aP2-/- animals failed to express TNF-α, a molecule implicated in
obesity-related insulin resistance. They showed improved insulin sensitivity (Gokhan
et al., 1996).
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A study conducted by Uysal, Scheja, Wiesbrock, Bonner-Weir, and
Hotamisligil indicated that genetically obese mice that lack aP2 have improved
glucose and lipid metabolism. They found that aP2 deficiency in obese mice not only
improved insulin sensitivity but also preserved the functioning of β cells.
Mice with aP2 deficiency were bred with mice having a heterozygous leptin
gene. The cross between mice with thr heterozygous leptin gene and aP2 deficiency
generated OB/ob-aP2+/- mice. These mice were again intercrossed to generate
OB/ob-aP2-/- and OB/ob-aP2+/+ mice.
The cross amongst themselves produced either aP2+/+ or aP2-/- animal. All
ob/ob homozygous mice developed obesity. The results showed that ob/ob- aP2-/mice had improved glucose metabolism compared to ob/ob- aP2+/+ mice. Despite
being extremely obese, aP2-/- mice showed similar results (Uysal et al., 2000).
The Inflammatory Pathways Leading to Insulin Resistance
Almost two decades ago, the discovery of increased expression of the
proinflammatory cytokine TNF-α in the adipose tissue of obese mice was the first
indication that inflammatory mediators were associated with obesity. The changes in
inflammatory signaling by adipocytes and the infiltration of immune cells into the
adipose tissue results in obesity -induced insulin resistance and associated metabolic
disease in animal models and humans. An important question, which arises when
studying all the model systems, is why the ability to convert surplus energy into fat
that has been preserved through the course of evolution becomes harmful to the
body?
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Nutritional abundance results in sequestering of the excess fuel in adipocytes,
which is followed by continual demand on storage and processing of lipids. The
adipocytes show signs of stress when they experience threshold. The stress is
exhibited as hypertrophy (increase in the volume of adipose tissue due to lipid
accumulation) within the cell, hypoxia (inadequate oxygen supply to the cells),
disruption of mitochondrial function, production of reactive oxygen species,
endoplasmic reticulum stress, apoptotic signaling, altered adipokine signaling,
elevated production of TNF-α and increase in the release of fatty acid (Hummasti &
Hotamisligil, 2010).
Adipocytes and macrophages have overlapping functions in obesity. When
there is inflammation, macrophages co-localize in the adipose tissue. Macrophages
express adipocyte gene products such as adipocyte/macrophage FABP aP2
(FABP4) and PPARƳ, while adipocytes may express macrophage proteins such as
TNF-α and IL-6.
The intracellular lipids can also have anti-inflammatory function. Peroxisome
proliferator-activated receptor (PPAR) and liver X receptor (LXR) belong to the family
of nuclear hormone receptor. LXRs regulate the homeostasis of cholesterol, fatty acid
and glucose; oxysterols, the oxidative derivative of cholesterol are ligands of LXR.
Macrophages undergo apoptosis in the absence of LXR. Thus LXR is crucial for the
response of macrophages to infection (Wellen & Hotamisligil, 2005).
PPARs regulate the metabolism of carbohydrates, lipids and proteins. They
also regulate the differentiation of preadipocytes into adipocytes. PPARs enhance
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the transcription of genes, which are important for lipogenesis. Fatty acid is a ligand
for PPAR. The activation of PPARƳ inhibits inflammatory gene expression in
macrophages and adipocytes through the suppression of NF-kB.
Preadipocytes under some conditions may differentiate into macrophages and
show antimicrobial and phagocytic properties. Under normal conditions, insulin binds
to the receptors on the insulin responsive cells thereby stimulating the insulin
receptor. The insulin receptor is a tyrosine kinase; it autophosphorylates itself and
many other substrates, including the members of the insulin receptor substrate family
(IRS). Upon tyrosine phosphorylation the substrates interacts with a series of
signaling proteins, thereby initiating different signaling pathways (Saltiel & Pessinb,
2002).
The exposure of cells to TNF-α or excess free fatty acids causes the inhibitory
phosphorylation of the serine residue of IRS-1. This phosphorylation not only reduces
the tyrosine phosphorylation of IRS-1 in response of insulin but also inhibits the
association of IRS-1 with the insulin receptor. These events inhibit the downstream
signaling and insulin action. Studies have shown that mice lacking the IRS-1 protein
are insulin resistant but they do not develop diabetes (Saltiel & Pessinb, 2002).
High levels of TNF-α and free fatty acids are also potent activators of JNK
(c-Jun N-terminal kinases). JNKs belong to the mitogen-activated protein kinase
family that play an important role in cellular apoptosis and are responsive to stress
stimuli such as cytokines.
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JNK phosphorylates many cellular proteins, including IRS-1and IRS-2.
Previous studies have indicated that the major JNK phosphorylation site in rat IRS-1
is located at Ser 307 and in humans is located at Ser 312. A study conducted by
Aguirre, et al., on mammalian and yeast cells revealed that Ser 307 is near the PTB
(phosphotyrosine binding domain) domain of IRS-1. Phosphorylation of this residue
might disrupt the interaction between IRS-1 and the insulin receptor. These events
might degrade IRS-1 or make it inaccessible to the activated insulin receptor, thereby
impairing insulin action paving the way for type-2 diabetes (Aguirre et al., 2002).
The absence of JNK results in decreased adiposity, improved insulin
sensitivity and enhanced insulin receptor signaling capacity. It has been shown that
dietary and genetic (ob/ob) mice models have increased JNK activity in the tissues.
Mice lacking either JNK1 (Jnk1-/-) or JNK2 (Jnk2-/-) and their controls (Jnk1-/- , JNK +/-)
were kept on a high fat diet. On the high fat diet both control and Jnk1-/- mice
developed obesity, but a section of adipose tissue from Jnk1 -/- mice had decreased
adipocyte size compared to the wild type. The absence of JNK-1 resulted in
protection from obesity-induced insulin resistance (Hirosumi et al., 2002).
Due to infusion of lipids, there is an increase in the levels of intracellular fatty
acid metabolites—e.g., diacylglycerol (DAG) and fatty acid COA’s. DAG is an
activator of PKC-θ and facilitates its translocation from the cytosol to the plasma
membrane. These stimuli can also activate JNK1 and IKKβ along with PKC-θ. They
associate with IRS-1 and phosphorylate IRS-1 at Ser 307, thereby impairing insulin
action.
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IKKβ is an enzyme and it is a protein subunit of IkB kinase. IKKβ inhibits
insulin action by two pathways. In the first pathway, it phosphorylates IRS-1 at Ser
307. In the second pathway it phosphorylate the inhibitor of IkB. IkB plays a key role
in regulating the immune response to infection. In the absence of the inhibitor, IkB
gets activated and on sensing inflammation produces TNF-α and IL-6. Mice
heterozygous for a null mutation in IKKβ are partially protected against insulin
resistance (Wellen & Hotamisligil, 2005).
The inhibition of IKKβ by high dose aspirin treatment has shown to improve
insulin signaling in humans (Hundal et al., 2002). All the above studies indicate that
fatty acids are vital components of many biological processes and are crucial in the
pathogenesis of many diseases. A-FABPs act at the intersection of metabolic and
inflammatory pathways.
aP2 and Ibuprofen
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) have been implicated in
improving insulin sensitivity. NSAIDs act as modulators of PPARƳ. They activate
PPARƳ and induce adipogenesis by inhibiting NF-kB signaling pathway.
Indomethacin, a derivative of ibuprofen can induce the differentiation of the
preadipocyte 3T3-L1 cell line and improve insulin sensitivity while functioning as
PPARƳ agonists (Zhang et al., 2009).
Ibuprofen has also been found to activate PPARƳ and promote adipocyte
differentiation. Rats, when treated with ibuprofen and Indomethacin, have shown
reduced serum triglycerides and cholesterol levels Pharmacological agents that can
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modify the function of A-FABP’s are of interest for controlling lipid signaling
pathways, metabolic regulation and inflammatory responses in a tissue specific or
cell specific manner.
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Chapter 2: Materials and Methods
Transformation Reaction
Bacterial cells, ECOS21, were transformed with the pET11b-aP2 plasmid
vector, which has an insert for aP2 gene and ampicillin resistance selection marker.
A microcentrifuge tube containing ECOS21 cells (50µl) was kept under tap water for
20 seconds. 1µl of plasmid DNA (2ng/µl) was added to it and was vortexed for 1
second.
The microcentrifuge tube was immediately placed on ice for 5 minutes. It was
heat shocked at 42ºC for 45 seconds and then immediately plated on an ampicillin
containing LB agar plate. The plasmid used was antibiotic resistant, so only the cells
that got transformed grew on the plate. The plates were kept overnight in a 37ºC
incubator.
Expression of aP2
Single colonies of the E.coli strain harboring the plasmid containing the
adipocyte lipid-binding protein insert were inoculated into 5 mL LB broth aliquots with
10 µl of ampicillin stock (100mg/ml) added. The test tubes were kept overnight in a
shaking incubator, which was maintained at 37ºC.
Next day, 500 µl of the media was inoculated in four flasks, each containing
500 ml LB broth. 500 µl of ampicillin stock were added to the flasks and they were
kept in a shaking incubator. The culture was grown until it reached an OD of 0.6 @
600nm. To induce the expression of aP2 protein, 1mM IPTG was added.
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Harvesting aP2
The culture was then allowed to grow 3 additional hrs and subsequently
harvested by centrifugation using a JS-4.2 rotor @ 4,000rpm at 4ºC for 20 min. 6.8
gm of cell paste was recovered from 1 liter of culture. The supernatant was discarded
and the pellet was kept in a - 20ºC freezer.
Cell Lysis
The pellet was resuspended in 50 ml lysis buffer. The lysis buffer contained
50mM Tris and 20mM EDTA at a pH of 8.0. To disrupt the cells the resuspended
pellet was passed through a M-110L pneumatic microfluidizer from Microfluidics. The
lysate was centrifuged @ 14,000 rpm for 30 min, using a JA-20 rotor. This step
removed the cell debris. The supernatant was collected and the pellet was discarded.
Purification of the Protein Using Q Sepharose Column
Q Sepharose is a medium used for anion exchange chromatography. In anion
exchange chromatography, a resin rich in positive charge is used and negatively
charged proteins associate with the positive charge on the resin. The more negative
the species, the tighter it binds to the column. Positively charged and neutral
molecules do not bind and elute through the column. A study conducted by Singh
and Bourdon found that the isoelectric point of aP2 is 7.6 (Singh, Rondeau, Hoareau,
& Bourdon, 2007). Since, aP2 is relatively neutral at a pH of 7.4, it interacted very
weakly with the column and eluted relatively unfettered.
As a column buffer 10mM HEPES and 1mM EDTA was used. The buffer was
maintained at a pH of 7.4. The column was attached to an optical detector, which
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detects absorbance @ 280nm. The absorbance is used as a proxy for protein
concentration. 10ml of the supernatant were loaded onto the column. The fractions
were collected until the detector showed a baseline of zero. The negatively charged
proteins that were bound to the column were then eluted by washing the column with
high salt (1M NaCl). The column was re-equilibrated by washing it with 10 column
volumes of the buffer.
Recombinant aP2 was identified by SDS-PAGE. The fractions containing aP2
were pooled and concentrated using a Centricon centrifugal filtration device. The
protein was centrifuged using a JS 4.2 swing bucket rotor at 3,750 rpm for 10 min.
The concentrator had a cut off of 10kDa and hence the buffer can flow through the
membrane while retaining proteins above 10kDa.
Purification of the Protein Using SP Sepharose Column
The concentrated protein was collected and loaded onto a sulfopropylSepharose cation exchange column, which is used for cation exchange
chromatography. The resin consists of long-chain dextran, a polymeric carbohydrate
of many repeating units joined together by covalent bonds. Dextran is coupled to a
cross linked agarose matrix. The stable agarose matrix and the flexible chains of
dextran increases the exposure of SP charged groups and also allows the passage
of charged protein molecules.
The column was equilibrated with 10mM HEPES and 1mM EDTA at a pH of
7.4. The fractions containing aP2 were identified by SDS-PAGE and pooled together.
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They were concentrated using a Centricon centrifugal filtration device as described in
the above step.
Removal of Fatty Acid by Lipidex 1000 Chromatography
The concentrated protein (30 mg/ml) was warmed at 37 ºC and applied to a
pre-warmed Lipidex 1000 column equilibrated with buffer containing 10mM HEPES
and 1mM EDTA at a pH of 6.0. This step is designed for temperature dependent
removal of the sequestered fatty acids from protein-fatty acid complexes (Glatz and
Veerkamp, 1983). The aP2 protein was left on the Lipidex column for 20 min at 37
ºC.
The protein was then washed off the column using the column buffer. The
fractions containing aP2 were pooled together and concentrated to 8.6 mg/ml using a
Centricon centrifugal filtration device. A 10 fold molar excess of Ibuprofen was added
to the concentrated protein and it was incubated at room temperature for 1 hour.
Protein Crystallization and Data Collection
A 1M stock solution of Tris HCl at a pH of 8.0 and a 3.5M stock solution of
Ammonium sulfate were prepared to serve as components of well solution. Table 2
shows the concentration range of ammonium sulfate (2.14 M to 2.42 M) and the
concentration of Tris-HCl (0.1 M), used to determine conditions ideal for
crystallization. The crystals were grown using the hanging drop method.
A small droplet of the protein (1µl) was mixed with the crystallization reagent (1µl)
and mounted on a siliconized cover slide; this slide was inverted over the reservoir.
The initial concentration of reagent in the droplet was less than that of the reservoir.
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The reservoir pulled water from the droplet until an equilibrium point was reached
between them.
Small needle shaped crystals were formed within 4-5 days at room
temperature. These crystals were isolated and used as seeds by transferring them
into a 2 µl drop of 8.6 mg/ml fresh aP2 and mother liquor. 1µl of fresh aP2 was added
to it every day and big crystals were observed in 3-4 days.
The crystals were soaked in a cryoprotectant consisting of 1:4 glycerol and
well solution and flash frozen in liquid nitrogen. For the purpose of data collection the
crystal was mounted on a goniometer head, which was adjusted to center the crystal
in the X-ray beam and also allowed rotation. The flash frozen crystal was held in a
stream of cryo-cooled nitrogen gas.
The crystal diffracted the X-ray beam into discrete beams, which produced a
reflection on the screen. The optical scanner measures the position and intensity of
each reflection by measuring the optical absorbance of the spot on the screen. This
information was sent to the computer in digital form.
The structure of human aP2 was solved by using the phases from the 2nnq
model of the RCSB Protein Data Bank. The structure was initially refined using
phenix refine without ibuprofen being modeled; clear electron density was seen for
bound ibuprofen. Finally ibuprofen was manually modeled and refined to 1.4 Å
resolution.
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Table 2
Crystallization conditions. Shows different conditions in a 24 well plate, which was
used to grow crystals. The concentration range of Ammonium sulfate changes from
2.14 M- 2.42 M in the rows, whereas the concentration of Tris remains the same.
AS
2.14M
611
100
289

2.196M
627
100
273

2.252M
643
100
257

2.308M
659
100
241

2.364M
675
100
225

2.42M
691
100
209

AS
Tris (0.1M)
Water

611
100
289

627
100
273

643
100
257

659
100
241

675
100
225

691
100
209

AS
Tris (0.1M)
Water

611
100
289

627
100
273

643
100
257

659
100
241

675
100
225

691
100
209

AS
Tris (0.1M)
Water

611
100
289

627
100
273

643
100
257

659
100
241

675
100
225

691
100
209

AS
Tris (0.1M)
Water
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Chapter 3: Results
Protein Purification
The expression and purification protocol for recombinant aP2 was established
by Chinander and Bernlohr. The protocol has been changed many times according to
the need of the experiment. In this study aP2 was purified using anion and cation
exchange chromatography and the purified protein was delipidated using Lipidex
1000 chromatography. The recombinant aP2 was identified by SDS-PAGE gel
electrophoresis. The purified protein was then crystallized using the hanging drop
method with seeding.
SDS-PAGE analysis in Figure 2 shows the crude bacterial lysate in lane 7.
The bands across the 14.4 KDa protein marker corresponds to aP2 protein. Lane 7
and 8 both show a thick band for aP2, suggesting over-expression of the aP2 protein.
Lane 1 shows the protein that was passed through the anion exchange column. It
can be clearly seen that this step resulted in removing the interfering proteins by
passing them through the column.

32

Figure 2
SDS PAGE analysis. The numbers to the left of the gel show the molecular mass of
the standards in kilodaltons. Lane 7 shows a sample of the bacterial lysate and in
lane 8 the lysate was diluted. Lane 1 shows Q Sepharose purified protein.
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Figure 3
The polyacrylamide gel electrophoresis analysis of the aP2 protein during the course
of purification. The numbers to the left of the gel show the molecular mass of the
standards in kilodaltons. Lane 1, E.coli extract; lane 2 pool from Q Sepharose
column; lane 3 SP Sepharose purified protein and lane 4 shows the delipidated
protein which was passed through the Lipidex 1000 column. A light smear on the gel
that is migrating faster than aP2 is phospholipids. It sometimes co-purifies with aP2.
The band across 14.4 KDa marker lane corresponds to aP2.
During the course of purification starting from the bacterial lysate to SP
Sepharose chromatography it was observed that aP2 was purified from the
interfering proteins. A light smear on the gel that is migrating faster than aP2 are
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phospholipids, which sometimes co-purifies with aP2 (Xu, Buelt, Banaszak, &
Bernlohr, 1991).
The protein-bound fatty acid was removed from the aqueous solution in a
temperature dependent manner using Lipidex 1000 chromatography at 37°C.
Comparing lanes 3 and 4 from figure 3 it can be said that this was achieved without
the loss of protein as the bands look equal in size.
Crystallization and Data Collection
To examine whether the crystals were protein or salt crystals methylene blue
was added to the drop harboring the crystals. Figure 4 clearly shows the presence of
protein crystals as they turned blue in color. Figure 5 shows the seeding helped in
growing bigger crystal. At 2 M ammonium sulfate and 10.4 mg/ml protein
concentration small crystals were observed, as shown in panel A. These crystals
were used as seeds for further crystallization experiments. Bigger crystals were
observed at 2.42 M ammonium sulfate concentration and lower protein concentration
between 8.6 to 8.0 mg/ml. These crystals gave diffraction data to 1.4 Å resolution.
The entire set was collected to 1.4 Å resolution using the detector system. The
statistical analysis of the combined x-ray data is presented in Table 3.
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Figure 4
Protein crystals stained with methylene blue. To test for protein crystals the crystals
were stained with methylene blue. Crystals that appear blue corresponds to aP2
protein crystals.
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A

B

C

D

Figure 5
Crystal images. The figure shows that changing the crystallization conditions
produced bigger crystals. Panel A has shows many small crystals these crystals were
used as seeds.

37
Table 3
X-ray data collection statistics of the native data set for crystalline aP2.
___________________________________________________
Summary of data collection statistics
____________________________________________________
Spacegroup
P212121
Unit cell dimensions
32.20 53.64 74.44
90.00 90.00 90.00
Resolution range (Å)
29.56 - 1.40 (1.45 - 1.40)
Total number of reflections
114166
Number of unique reflections
24732
Average redundancy
4.62
(2.27)
% completeness
94.8
(67.6)
Rmerge
0.039
(0.428)
Reduced ChiSquared
0.97
(1.20)
Output <I/sigI>
19.4
(1.4)
____________________________________________________
The lattice type was orthorhombic with unit cell dimensions of a = 32.20 Å, b =
53.64 Å, c = 74.44 Å. The space group was P212121 and there was one molecule of
aP2 per asymmetric unit.
The Rmerge shows agreement between the averaged intensities for all
observations of one reflection with the calculated intensities of individual observations
of the same reflection. The individual intensities agree with their averages within 3.9
%. The percentage completeness for the data set was 94.8% and each reflection was
measured about 5 times.
Refinement
For partly refined x-ray data clear electron density was seen for without
ibuprofen being modeled. Finally ibuprofen was manually modeled as shown in
Figure 6. The green density refers to positive electron density. Figure 7 shows the
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difference map and the negative densities for the Fo - Fc are almost negligible. The
backbone electron densities look continuous and it looks like a space filling model of
the protein. The 2Fo – Fc map shows agreement with the model and no empty
electron densities have been observed.
The electron density for Ibuprofen was found to fit both stereoisomer of
Ibuprofen as seen in Figure 8. Careful inspection of the model reveals that in the S
form the oxygen at the O2 position of the carboxyl group of Ibuprofen formed
hydrogen bonds with the hydroxyl group of Tyr 128 as well as with the NE nitrogen
and NH2 nitrogen of Arg 126. The other oxygen at the O1 position also interacted
with Tyr 128 via water mediated hydrogen bond. This bonding is not seen in the case
of fatty acids.
In the R form, the oxygen at the O1 position of the carboxyl group of Ibuprofen
formed hydrogen bonds with the hydroxyl group of Tyr 128 as well as the NE nitrogen
of Arg 126. The oxygen at the O2 position formed a direct H bond with the NH2
nitrogen of Arg 126.These are the two key interactions for aP2 ligands.
The role of water in the binding site is to stabilize the bound ligand. Four new
water molecules, which are shown in blue (Figure 9) were observed. They were
found to interact with other water molecules.
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Figure 6
Partly refined x-ray data. The figure shows the positive density, shown in green, was
clearly seen for ibuprofen.
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Figure 7
Electron density map using the final phases showing both stereoisomer of Ibuprofen.

S Ibuprofen

R Ibuprofen

Figure 8
Interactions between ibuprofen carboxylate group and the protein. A portion of the
refined model of aP2 with bound ibuprofen showing hydrogen bonds with the
neighboring amino acids indicated by red and blue lines.
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Figure 9
Ibuprofen with additional water molecules. A space filling model of fatty acid in the
background showing ibuprofen displacing the fatty acid. The waters shown by blue
color are the water molecules that are added during this process.
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Chapter 4: Discussion
Fatty acid bound to aP2 protein cannot be compared to an enzyme-substrate
complex, where the enzyme-binding site resembles the shape of the substrate. The
binding cavity of aP2 is different from the shape of the fatty acid and permits other
ligands to bind. Compounds having a lipophilic backbone linked to an acid moiety,
usually a carboxylate binds at the active site. Ibuprofen and other NSAIDs, such as
indomethacin, share this structural similarity. Ibuprofen has been shown to increase
peroxisomal β–oxidation with indomethacin being less active (Foxworthy, Perry, &
Eacho, 2003).
The focus of this study was the purification of the aP2 protein and its cocrystallization with Ibuprofen to study its interaction with the amino acids that play a
key role in the binding of a ligand. The aP2 protein was expressed in E. coli and it
was purified using ion exchange chromatography. The overexpression of aP2 protein
can be judged by looking at Figure 2. The purification was monitored by SDSpolyacrylamide gel electrophoresis. The aP2 protein was separated from the
contaminant proteins and the results are summarized in Figure 3, which shows
homogenous aP2 across the 14.4 KDa marker.
Crystallization experiments were successful using macroseeding. The crystals
gave diffraction data to 1.4 Å resolution. The statistical details of the combined x-ray
data set are recorded in Table 3. The lattice type was orthorhombic and the unit cell
dimensions were, a = 32.20 Å, b = 53.64 Å, c = 74.44 Å.
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To determine the space groups the computer program examined the x-ray
data for symmetry and systematic absences, which described the internal symmetry
in the unit cell. It observed the reflections with h, k or l = 2n along the reciprocal axes.
This indicated that the space group was P212121. The data set was 98.4 % complete.
Each reflection was shown to be measured 5 times. Redundancy improved accuracy
because when the reflection was measured more than once its average was more
accurate than the single observation.
The R-work was 0.1557 and R-free value was 0.1984. The R-free was
computed with a set of intensities that were not included during refinement. R-work
evaluated the whole data set but R-free was a quality control process, which gave the
information on how accurate the current model was when it measured the intensities
that were not included in the refinement. During refinement the R-free value was
higher compared to R-work. R-free value decreased with the R-work when
refinement was in process showing agreement between the calculated and the
observed data.
Figure 8 shows that the electron density for Ibuprofen was found to fit both
stereoisomers of Ibuprofen and in both the forms. The carboxyl group of Ibuprofen
formed hydrogen bonds with the hydroxyl group of Tyr 128 as well as the NE nitrogen
of Arg 126. The binding of fatty acid within the cavity appears due to the network of
hydrogen bond between four species: 1) carboxylate group of the fatty acid, 2) the
two guanidine group from Arg 106 and Arg 126, 3) hydroxyl group of Tyr 128, and
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4) the intervening water molecule located between the carboxylate group and Arg
106.
Figure 8 clearly shows that the fourth condition was not met in both the S and
the R forms. In the S form, the interaction between the carboxylate group and Arg
106 was mediated via two water molecules and in the R form, no interaction was
found. This can be the reason that points towards the possibility of ibuprofen being a
weak inhibitor of aP2 protein. It was also observed that Ibuprofen did not encounter
hydrophobic interaction with Phe 57. The four additional water molecules shown in
Figure 9 were found and they may assist in stabilizing ibuprofen at the binding site.
Ibuprofen is a non-steroidal anti-inflammatory drug and a cyclooxygenase inhibitor. It
has been implicated as a potent PPARƳ activator. Cyclooxygenases (COX) regulates
the production of eicosanoids and exists in two isoforms COX–1 and COX–2. COX–1
is expressed constitutively in most tissues. It regulates the basal levels of
prostaglandins (PGs), because their increased levels trigger inflammation. The
expression of COX–2 is induced by inflammatory cytokines and is responsible for
high levels of prostaglandins (Linton & Frazio, 2003). Ibuprofen and indomethacin
both are nonspecific to COX and higher doses can be harmful to the body with a
variety of detrimental side effects like gastrointestinal ulceration.
The information on the influence of NSAIDs on PPARs may be used to design
drugs that can minimize the potential for unwanted side effects. The aP2 inhibitor
should also be selective versus muscle FABP and epidermal FABP. Epidermal FABP
is expressed in various tissues including adipose, macrophage, stomach, heart,
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brain, liver, muscle, lung and endothelial cells. The muscle FABP is expressed in
heart and skeletal muscle. It has been related to the oxidation of fatty acid in these
tissues, which is important for their proper function. A non-selective inhibitor can
cause side effects, thus selectivity for mFABP over eFABP is crucial for an aP2
inhibitor (Sulsky et al., 2007).
BMS309403 is a potent aP2 inhibitor that has been designed logically to have
selectivity over mFABP and eFABP. It competitively inhibits the interaction of fatty
acid with the binding cavity. A fluorescent 1,8-anilino - 8 naphthalene sulfonate (ANS)
binding displacement assay was used to study the binding of the inhibitor to aP2,
muscle FABP and mal1. The inhibitor constant value of BMS309403 towards aP2
was found to be 2nM. This was much lower compared with 250nM for muscle FABP
and 350 nM for mal1. The high binding affinity of BMS309403 and selectivity for aP2
can be attributed to the interaction of the ligand with the key residues i.e. Tyr128, Arg
126 and Arg106.
AP2 inhibition by BMS309403 simulates the effects of the aP2 null mutation
and reduces the development of atherosclerotic lesions. These changes may be
brought about by effects on macrophage mediated inflammatory pathways given that
treatment with the inhibitor decreases the production of various pro-inflammatory
cytokines by macrophages as well increases APOA1 mediated cholesterol efflux
(decreasing the concentration of cholesterol esters in macrophages).
The inhibitor also produces effects in adipose tissue and elsewhere
downregulating adipocyte pro-inflamatory cell signaling pathways and reducing
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expression of pro-inflamatory cytokines. Physiological effects include increased blood
free fatty acids, reduced triglycerides, reduced adiponectin and increased adipocyte
and whole body insulin sensitivity. Unlike the effect of the aP2 null mutation, the
inhibitor did not produce a compensatory upregulation of Mal1 expression and
reduced fatty infiltration of the liver as compared to the aP2 null mutant. Models like
BMS309403 can provide a class of therapeutic agents for diseases such as type-2
diabetes (Furuhashi et al., 2007).
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Appendix

BMS309403

Ibuprofen

Indomethacin

The chemical structure of Ibuprofen, Indomethacin and BMS309403
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The figure shows inflammatory signaling pathways, which are involved in the
development of insulin resistance.

